HomeZBIO • NASDAQ
add
Zenas Biopharma Inc
Previous close
$11.43
Day range
$11.14 - $11.97
Year range
$9.55 - $26.11
Market cap
515.53M USD
Avg Volume
189.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.45M | 48.37% |
Net income | -38.61M | -208.42% |
Net profit margin | — | — |
Earnings per share | -5.02 | — |
EBITDA | -40.95M | -214.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 386.80M | 434.91% |
Total assets | 403.43M | 381.47% |
Total liabilities | 44.00M | 22.42% |
Total equity | 359.44M | — |
Shares outstanding | 41.79M | — |
Price to book | 1.33 | — |
Return on assets | -33.96% | — |
Return on capital | -39.32% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -38.61M | -208.42% |
Cash from operations | -31.06M | -197.53% |
Cash from investing | -26.76M | — |
Cash from financing | 233.98M | 1,069.90% |
Net change in cash | 176.11M | 239.65% |
Free cash flow | -20.05M | — |
About
Founded
2019
Headquarters
Website
Employees
115
